Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
Novel Folate Receptor alpha (FRα) binding peptides induce brain cell reprograming and rejuvenation, enhancing cognitive function in aged mice. These unique peptides are able cross the blood-brain barrier and specifically bind to neuroepithelial FRα.
Selective SGK1 kinase inhibitors, blood-brain barrier-permeable, as drug candidates for the treatment of neurodegenerative diseases (such as Parkinson’s or Alzheimer’s disease) or cardiovascular diseases (such as hypertension).
Analysis of TAF1 isoforms in blood and cerebrospinal fluid of controls and individuals with Multiple Sclerosis.
A conjugate of fatty acids and amino acids has been found to protect neurons and facilitate the removal of protein aggregates that cause the most common neurodegenerative diseases. This opens the possibility of new, more effective and cheap treatments.
The modulation of specific endogenous hormonal flows in neural routes has been observed to allow the modulation of social interaction preferences, opening the door to new therapies against social avoidance disorders

Social Media